Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.41 | Prev. Close $0.40 | Circuit Range N/A |
Day Range $0.39 - $0.41 | Year Range $0.35 - $4.26 | Volume 3,973 |
Average Traded $0.40 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $0.41 | $0.40 | +0.00% |
12-Nov-25 | $0.41 | $0.40 | +1.79% |
11-Nov-25 | $0.39 | $0.39 | -3.47% |
10-Nov-25 | $0.39 | $0.40 | +3.86% |
07-Nov-25 | $0.38 | $0.39 | -9.32% |
06-Nov-25 | $0.45 | $0.43 | +0.00% |
05-Nov-25 | $0.45 | $0.43 | -9.11% |